| Medical and Health Sciences | Lifetime | 596 | GR 2 | 99.97 |
| Clinical Neurology | Lifetime | 46 | GR 1 | 99.84 |
| Epidemiology | Lifetime | 178 | GR 2 | 99.78 |
| Rheumatology | Lifetime | 473 | GR 2 | 97.97 |
| Cellular and Molecular Neuroscience | Lifetime | 908 | GR 2 | 95.48 |
| Medical Genetics | Lifetime | 554 | GR 2 | 94.34 |
| Dermatology | Lifetime | 853 | GR 2 | 89.50 |
| Clinical Neurology | 2021-2025 | 37 | GR 1 | 99.24 |
| Infectious Diseases | 2021-2025 | 806 | GR 4 | 79.67 |
| Inflammatory Myopathies and Dermatomyositis | Lifetime | 1 | GR 1 | 99.88 |
| Myasthenia Gravis and Thymoma | Lifetime | 4 | GR 1 | 99.83 |
| Skin Diseases and Diabetes | Lifetime | 3 | GR 1 | 99.78 |
| Peripheral Neuropathies and Disorders | Lifetime | 14 | GR 1 | 99.85 |
| Autoimmune Neurological Disorders and Treatments | Lifetime | 6 | GR 1 | 99.78 |
| Hereditary Neurological Disorders | Lifetime | 13 | GR 1 | 99.46 |
| Eosinophilic Disorders and Syndromes | Lifetime | 37 | GR 1 | 99.56 |
| Immunodeficiency and Autoimmune Disorders | Lifetime | 101 | GR 1 | 99.38 |
| Viral Infections and Immunology Research | Lifetime | 111 | GR 1 | 99.02 |
| Genetic Neurodegenerative Diseases | Lifetime | 86 | GR 1 | 99.26 |
| Muscle Physiology and Disorders | Lifetime | 128 | GR 2 | 98.99 |
| Muscle and Compartmental Disorders | Lifetime | 38 | GR 1 | 99.01 |
| Monoclonal and Polyclonal Antibodies Research | Lifetime | 577 | GR 2 | 99.02 |
| Neurogenetic and Muscular Disorders Research | Lifetime | 104 | GR 1 | 98.77 |
| Parkinson's Disease and Spinal Disorders | Lifetime | 21 | GR 1 | 98.67 |
| Long-Term Effects of COVID-19 | Lifetime | 463 | GR 7 | 96.50 |
| Neurological and metabolic disorders | Lifetime | 141 | GR 1 | 96.89 |
| Peripheral Nerve Disorders | Lifetime | 202 | GR 1 | 97.19 |
| Botulinum Toxin and Related Neurological Disorders | Lifetime | 580 | GR 2 | 97.06 |
| Cardiomyopathy and Myosin Studies | Lifetime | 656 | GR 2 | 96.93 |
| Glycogen Storage Diseases and Myoclonus | Lifetime | 272 | GR 1 | 95.55 |
| Multiple Sclerosis Research Studies | Lifetime | 795 | GR 2 | 95.67 |
| Blood disorders and treatments | Lifetime | 745 | GR 3 | 92.93 |
| Celiac Disease Research and Management | Lifetime | 724 | GR 2 | 92.32 |
| Heterotopic Ossification and Related Conditions | Lifetime | 127 | GR 1 | 91.43 |
| Skin and Cellular Biology Research | Lifetime | 866 | GR 4 | 91.43 |
| Dermatological and Skeletal Disorders | Lifetime | 880 | GR 6 | 86.52 |
| Hypertrophic osteoarthropathy and related conditions | Lifetime | 87 | GR 1 | 77.28 |
| Myasthenia Gravis and Thymoma | 2021-2025 | 6 | GR 1 | 99.21 |
| Peripheral Neuropathies and Disorders | 2021-2025 | 18 | GR 1 | 99.13 |
| Autoimmune Neurological Disorders and Treatments | 2021-2025 | 10 | GR 1 | 98.91 |
| Genetic Neurodegenerative Diseases | 2021-2025 | 656 | GR 2 | 83.94 |
| Inflammatory Myopathies and Dermatomyositis | 2021-2025 | 714 | GR 7 | 73.82 |
